The United States Food and Drug Administration (USFDA) had conducted
pre-approval inspection at the company's drug formulations facility in
Kothur village during the period from March 2 to 6, 2020, Natco Pharma
said in a filing to the BSE.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-eir-from-usfda-for-telangana-facility/articleshow/75372932.cms
No comments:
Post a Comment